CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 106 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2015. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $317,000 | -92.8% | 2,956 | -91.7% | 0.02% | -93.7% |
Q3 2016 | $4,420,000 | +78.8% | 35,509 | +52.7% | 0.30% | +81.8% |
Q2 2016 | $2,472,000 | +255.7% | 23,254 | +283.0% | 0.16% | +200.0% |
Q1 2016 | $695,000 | +99.7% | 6,071 | +148.3% | 0.06% | +103.7% |
Q4 2015 | $348,000 | +397.1% | 2,445 | +212.7% | 0.03% | +440.0% |
Q3 2015 | $70,000 | – | 782 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPQ Asia Capital Ltd | 287,277 | $35,760,000 | 28.32% |
WARBURG PINCUS LLC | 6,674 | $830,780,000 | 13.45% |
Ariose Capital Management Ltd | 238,841 | $27,689,000 | 7.56% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 12,600 | $1,568,000 | 4.48% |
RUDMAN ERROL M | 37,001 | $4,606,000 | 3.72% |
INDUS CAPITAL PARTNERS, LLC | 245,237 | $30,527,000 | 2.89% |
Ativo Capital Management LLC | 93,784 | $11,674,000 | 2.70% |
OBERWEIS ASSET MANAGEMENT INC/ | 63,305 | $7,880,000 | 2.27% |
Point72 Hong Kong Ltd | 31,500 | $3,921,000 | 2.14% |
Cormorant Asset Management, LP | 112,867 | $14,050,000 | 1.55% |